Medicap Pharmacy
The total investment to open a Medicap Pharmacy franchise ranges from $50,000 to $408,680. The initial franchise fee is $50,000. Ongoing royalties are 3% plus a 0.5% advertising fee.
What is the Medicap Pharmacy franchise?
Medicap Pharmacy offers entry into community pharmacy and other essential healthcare services through a structured franchise model. The brand was founded in 1971 in Des Moines, Iowa, although another source lists 1972, and began as Medicine Chest, a retail concept built around patient care, convenience, and pharmaceutical cost savings. Franchising began in 1973, with another source citing 1974. Medicap Pharmacy operates under Medicine Shoppe International, or MSI, part of Cardinal Health. Medicine Shoppe International, Inc. acquired Medicap Pharmacies Inc. in December 2003, when Medicap franchised 181 community pharmacies across 34 states. The main office is in West Des Moines, Iowa, with corporate facilities in Dublin, Ohio. The franchise database reports 56 total units, 96 franchised units, and 0 company owned units. Other market estimates value global pharmacy at USD 2.4 trillion in 2024, with growth to USD 4.1 trillion by 2035. PeerSense presents independent franchise research for buyers reviewing this opportunity and its financing needs. PeerSense is a commercial capital advisory firm, not a lender.
The pharmacy industry has several reported market size estimates. One places the global market at USD 1.35 trillion in 2024 and USD 2.06 trillion by 2030. Another estimates USD 1.49 trillion in 2025 and USD 1.96 trillion by 2030. A separate estimate lists USD 1,315.2 billion in 2023 and USD 1,914.6 billion by 2032. Another places the market at USD 2.4 trillion in 2024, USD 2.5 trillion in 2025, and USD 4.1 trillion by 2035. Reported compound annual growth rates range from 4.3% for 2023 to 2032 to 7.3% for 2025 to 2030, with 5% projected for 2024 to 2035. Stable healthcare needs, an aging population, and higher prescription volumes support demand. Chronic conditions including cancer, diabetes, and cardiovascular disease affect approximately 133 million Americans and contribute to higher healthcare spending. Pharmacies are investing in analytics and personalization as customer focused models gain ground. Over the counter products are projected to grow at a compound annual growth rate of 7% to 8% from 2025 to 2030, while e pharmacy is projected to grow at 12% to 13% over the same period. Digital prescription systems and value based care are also changing distribution and service delivery.
Reported Medicap Pharmacy investment figures vary by source and business model. The franchise fee is listed as $50,000 in the database, while web research reports $3,000 to $15,000. Another source lists as much as $193,940, so buyers should review the current Franchise Disclosure Document. The database reports total initial investment of $50,000 to $408,680. Other estimates place the average initial investment at $130,000 to $961,000 for a franchised center. A new location is estimated at $478,050 to $961,440, while converting an existing pharmacy is estimated at $130,000 to $582,440. Additional reported ranges are $22,100 to $447,000, $330,050 to $699,414, $330,050 to $690,039, and $130,000 to $894,876. These figures compare with sub sector averages of $294,531 to $623,123 and reflect inventory, equipment, and regulatory requirements. Ongoing fees include a royalty of 3% of gross sales and a marketing and advertising fee of 1% of gross sales. Reported liquidity requirements include about $55,000, another source’s minimum cash range beginning at $65,000, and working capital of $50,000 to $70,000. MSI and its parent, Cardinal Health, provide corporate infrastructure and may affect financing considerations. The overall investment falls within a mid to premium range for franchise buyers.
The operating model combines prescription fulfillment with expanded health services and community relationships. Services include immunizations, point of care testing, one on one consultations, medication packaging, medication synchronization, diabetes care supplies, medical equipment, glucose testing, and cholesterol screening. These services generally require qualified pharmacists and support staff, although specific staffing requirements are not detailed. Medicap Pharmacy provides initial training for new franchisees, while one source reports an initial training program of 0 hours, potentially indicating experienced pharmacist or pre qualification expectations. Item 11 of the Franchise Disclosure Document should provide the program’s length and content. Ongoing support includes a Franchise Business Consultant, along with specialists in marketing, managed care, operations, and finance. The franchisor also assists with compliance, location selection, reimbursement processes, and other needs of independent pharmacy owners. Franchisees can connect with a pharmacist network to share practices and compare performance. Preferred locations generally have aging demographics, limited pharmacy competition, strong healthcare infrastructure, and stable economic indicators. The stated population focus is communities of 10,000 to 50,000, especially areas with limited access to personalized pharmacy services.
Industry figures provide context rather than a unit level forecast. The global pharmacy market is reported at USD 1.35 trillion in 2024 with a projection of USD 2.06 trillion by 2030, and elsewhere at USD 2.4 trillion in 2024 with growth to USD 4.1 trillion by 2035. Forecast compound annual growth rates range from 4.3% to 7.3%. Medicap grew from 28 Iowa pharmacies in 1981 to its 100th location in 1993 and currently reports 96 franchised units and 56 total units in the database. As of 2020 Franchise Disclosure Document data, the brand operated in 24 states, including 41 Midwest locations. MSI and Cardinal Health provide corporate resources that may support unit operations and market positioning. Services such as immunizations, point of care testing, and specialized consultations may create additional revenue sources. Buyers must assess the reported investment of $50,000 to $408,680 in franchise data, or $130,000 to $961,000 in web research, against demand associated with chronic disease and an aging population.
Medicap Pharmacy expanded to 28 Iowa pharmacies by 1981 and opened its first Minnesota location in 1984. The 100th pharmacy opened in 1993. Current sources report 56 total units and 96 franchised units in the franchise database, approximately 54 locations, 67 United States franchises, and 77 United States franchised locations in the 2020 Franchise Disclosure Document. One source reports 237 units in operation. MSI and Medicap stores together represent more than 800 United States locations and over 400 locations in five other countries. The December 2003 acquisition brought Medicap’s 181 community pharmacies in 34 states into Medicine Shoppe International and the Cardinal Health organization. The brand’s differentiation rests on recognition, supply chain and technology resources associated with Cardinal Health, and an emphasis on personalized care and convenience. Medicap is expanding beyond prescription filling through immunizations, point of care testing, and one on one consultations. E pharmacy is projected to grow at a compound annual growth rate of 12% to 13% from 2025 to 2030. The 41 Midwest locations across 24 states in 2020 Franchise Disclosure Document data provide an operating example for additional underserved markets.
A suitable franchise candidate will generally have pharmacy or related healthcare experience, required licenses, and knowledge of pharmaceutical operations and patient care. Specific experience requirements are not stated, but prior management experience in healthcare may help with daily operations and team leadership. Community health and patient focused service are central to the model. Target markets include communities of 10,000 to 50,000 residents with aging demographics, limited pharmacy competition, strong healthcare infrastructure, and stable economic indicators. Potential expansion areas include underserved markets in the Northeast and Southeast, building on the Midwest operating model. The timeline from signing to opening is not provided. The franchisor’s support includes location assistance and reimbursement management. The franchise agreement term is also unspecified and should be reviewed during due diligence.
A Medicap Pharmacy investment provides access to a pharmaceutical market projected to reach USD 4.1 trillion by 2035. Demand is supported by healthcare needs, aging demographics, and chronic diseases affecting approximately 133 million Americans. Reported unit counts vary, including 56 total units, 96 franchised units, and 77 franchised units in the 2020 Franchise Disclosure Document. The brand dates to 1971 and operates within the Cardinal Health organization. Its focus on communities of 10,000 to 50,000 residents and services beyond prescriptions may support expansion in underserved areas. Reported investment ranges include $50,000 to $408,680. PeerSense provides independent due diligence resources, including SBA lending history, a Loan Activity Score of 54, rated Moderate, location maps with Google ratings, Franchise Disclosure Document financial data, and comparison tools. Buyers can review the complete Medicap Pharmacy franchise profile on PeerSense.
Loan Activity Score
58/100
SBA Default Rate
3.8%
Active Lenders
61
According to its Franchise Disclosure Document or public business records, Medicap Pharmacy has 96 locations, all owned by franchisees. Public SBA loan records show 61 lenders made 131 loans to franchisees of Medicap Pharmacy. PeerSense calculates Medicap Pharmacy's score as 58 out of 100, using public SBA loan performance and recent lending activity. Cost figures are based on the 2023 Franchise Disclosure Document. To correct a figure, email the current FDD and the differing item numbers to info@peersense.com, and this page will be updated.
Franchising since 2025 · 96 locations
$50,000 to $408,680
$50,000
96
96 franchised
Proprietary PeerSense metric
ModerateDistinct lenders in public SBA records for Medicap Pharmacy
131
Total SBA loans
$223K
Average loan size
Source: public SBA 7(a) and 504 loan records through December 31, 2025
Referral fee at closing
SBA Lending Activity for Medicap Pharmacy
Loan Activity Score Breakdown
Major Brand (100+ loans)
Are lenders increasingly or decreasingly funding this brand? Growing trends score highest.
Blended default rate (recent + all time) compared to NAICS sector peers.
Quality lenders actively backing this brand, with penalty for lender pullback.
FDD availability, Item 19 disclosure, and overall data completeness.
Geographic spread of SBA funded locations across states.
SBA Lending Performance
SBA Default Rate
3.8%
vs 9.4% peer avg
SBA Loans
131
Total Volume
$29.2M
Active Lenders
61
7 selective
States
31
vs. SBA Sector Average
SBA loan default rate vs. all franchises in the same NAICS sector, not limited to direct competitors
Key Highlights
Franchise Financing Resources
Data Insights
Key performance metrics for Medicap Pharmacy based on SBA lending data
SBA Default Rate
3.8%
5.6% below peer avg
SBA Loan Volume
131 loans
Across 61 lenders
Lender Diversity
61 lenders
Avg 2.1 loans per lender
Investment Tier
Mid range investment
$50,000 to $408,680 total
Medicap Pharmacy: Deep SBA Data
Brand specific metrics derived directly from SBA 7(a) approval records: peak lending year, leading state, average loan size, and lender concentration. PeerSense computes these per brand so capital advisors and prospective franchisees can benchmark this opportunity against the rest of the franchise universe.
Peak SBA Year
2003
13 approvals. The best year on record for Medicap Pharmacy.
Top SBA State
Iowa
21 SBA financed Medicap Pharmacy locations, the densest operator footprint.
Average Loan Size
$223K
Median $150K. Use as a sizing anchor when modeling your own Medicap Pharmacy unit.
Lender Concentration
32.1%
Moderately Spread
Share of Medicap Pharmacy approvals captured by the top 3 SBA lenders.
Medicap Pharmacy's SBA lending pipeline peaked in 2003 (13 approvals). The last five fiscal years account for 1% of cumulative volume ($673K approved). Operator density is highest in Iowa with 21 SBA financed locations. Average funded ticket sits at $223K, with the median at $150K. Lender mix is moderately spread: the top three SBA lenders account for 32.1% of approvals. Meaningful choice exists, but specific lenders carry the brand.
Payment Estimator
Estimated Monthly Payment
$518
Principal & Interest only
Indicative only, as of November 1, 2026. Not a quote, commitment or offer of credit. Final pricing, leverage and terms are determined by the lender at underwriting, after full transaction materials are reviewed. PeerSense sources the file. The lender sets pricing. What these terms mean.
Locations
Medicap Pharmacy, unit breakdown
Explore Funding for Medicap Pharmacy
Our business financing consultants help connect you with the right lending partners. Referral fee paid at closing.
Or get an instant analysis
Scan Your Deal Instantly3 FDDs Available for Medicap Pharmacy
Review franchise fees, investment ranges, royalties, Item 19 financial data, and year over year trends. Request complimentary access through your PeerSense funding advisor.
Page Review
Reviewed by Edward L. Freeman, Founder and Managing Director, PeerSense
- PeerSense is a capital advisory firm that places commercial financing with direct capital sources; the capital source sets final terms.
- Edward L. Freeman founded PeerSense in January 2020.
- He is a Registered Franchise Consultant with Business Alliance, Inc., a credential issued in March 2022, and worked as a franchise consultant there from March 2022 to May 2023.
- His recorded experience includes a $22 million SBA construction loan, with about $16 million funded on the deal.
- In the 12 months through September 30, 2026, PeerSense tracked 912 publicly announced financings with a disclosed size of $361.32 billion. PeerSense Capital Data Report · Methodology page
Last reviewed LinkedIn profileAbout Edward Freeman